Elisa Agostinetto· @ElisaAgostinett · X·· 1 天前评分70
正文 · 原文
At #ESMO26 rapid oral session on advanced #breastcancer
@KalinskyKevin presents results from postMONARCH
Abema + fulvestrant showed numeric, non significant ⬆️ OS in aBC after PD to CDK4-6i
Modest PFS improvement
@OncoAlert
125 浏览 · 5 赞 · 4 转发 · 1 回复
会议摘要
1RO按 Rapid oral 1: Breast cancer, advanced stage 对上
Overall survival from the phase 3 postMONARCH trial of abemaciclib + fulvestrant vs placebo + fulvestrant for HR+, HER2- advanced breast cancer following progression on a prior CDK4/6 inhibitor + endocrine therapy
https://esmocongress.esmo.org帖内回复
- Elisa Agostinetto@ElisaAgostinett
Simultaneous publication in @Annals_Oncology ‼️ https://www.annalsofoncology.org/article/S0923-7534%2826%2908075-0/fulltext @OncoAlert @myESMO
来源：Elisa Agostinetto · x.com